关于palbociclib的营销后安全问题:对FDA不良事件报告系统的不成比例分析
Qian Cheng1, Xuan Shi1, Yazheng Zhao1
1Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Expert opinion on drug safety
|April 2, 2024
概括
这项研究使用FAERS数据库分析了palbociclib不良事件 (AE) 的现实数据. 关键发现突出显著的安全信号,包括骨髓衰竭和神经病变,为未来的乳腺癌治疗安全性研究提供信息.
科学领域:
- 药物监督和药物安全研究.
- 在瘤学中的真实世界证据 (RWE) 分析.
背景情况:
- 帕尔博西克利布是一种用于治疗乳腺癌的向疗法.
- 了解其现实世界的不良事件概况对于患者安全至关重要.
研究的目的:
- 使用美国食品和药物管理局不良事件报告系统 (FAERS) 数据库调查palbociclib和不良事件 (AE) 之间的关联.
- 确定和排列与palbociclib相关的AE的临床优先级.
主要方法:
- 使用不相称性分析来评估与palbociclib相关的副作用的信号强度.
- 副作用的评分和排名基于五个特征,进行了结果,发病时间和剂量报告分析.
- 进行了分层分析,考虑了性别和年龄等因素.
主要成果:
- 分析了超过61,000份palbociclib初级疑似报告和195,000份相关的副作用.
- 在系统器官类 (SOC) 和首选术语 (PT) 级别分别检测到18个和65个积极的安全信号.
- 有意义的信号包括骨髓衰竭,神经病变,多发性溢血,骨髓抑制,肺,肺血栓. 对AE的中位发病时间为79天.
结论:
- 该研究确定了与palbociclib相关的潜在副作用,并强调了特定的安全问题.
- 这些发现为乳腺癌患者的palbociclib安全性评估提供了有价值的数据.
- 建议进行前性临床试验,以验证这些现实发现.
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134
Hazard Ratio
118
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
118


